RealTech Magazine brings our readers the latest news and stories from around the world revolving around technology, business, crypto, and more.
vzphotos AbbVie (NYSE:ABBV) has continued to maintain near 100% market share for its blockbuster arthritis therapy Humira (adalimumab) despite the
You must be logged in to post a comment.